Reviewing the latest data on Australia's innovation performance.
The outcomes from the latest Australian Innovation Statistics appear positive at first glance. In case you missed it, we provide a summary of the highlights from this recent report. We also dig a little deeper to see that despite some positive indications, there are some concerning signs regarding Australia's innovation performance that should provide pause for thought and consideration of how businesses undertaking R&D can be better supported.
Streamlining R&D Tax Claims for Clinical Trials in Australia
Clinical trials have long been viewed favourably under the R&D Tax Incentive Program. To recognise this, the program offers an efficient registration process for trials registered with the Therapeutic Goods Administration, reducing the administrative burden for biotech companies. This streamlined approach, along with support through Advance Overseas Findings (AOF), empowers Australian biotech firms to innovate and lead on the global stage.